BRNS · CIK 0001828185 · operating
Barinthus Biotherapeutics plc. (BRNS) is a pharmaceutical preparations company incorporated in United Kingdom, listed on the Nasdaq. With a market capitalization of $25 million, Barinthus Biotherapeutics plc. is a micro-cap company. The stock currently trades at $0.61, up 4.78% today, with a 52-week range of $0.56–$2.92.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-1.55 | $-1.55 | +18.8% | |
| 2023 | $-1.91 | $-1.91 | -1464.3% | |
| 2022 | $0.14 | $0.14 | +107.1% | |
| 2021 | $-1.96 | $-1.96 | — |